Previous Close | 24.72 |
Open | 25.48 |
Bid | 22.01 x 100 |
Ask | 22.10 x 200 |
Day's Range | 21.79 - 25.48 |
52 Week Range | 20.67 - 40.89 |
Volume | |
Avg. Volume | 1,200,554 |
Market Cap | 3.068B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Comprehensive Analysis of ARWR's Fiscal 2024 Q2 Earnings Against Market Forecasts
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript May 9, 2024 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.01634 EPS, expectations were $-0.06. Arrowhead Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and […]
Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...